Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC252114 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9664 | High Similarity | NPC52097 |
0.959 | High Similarity | NPC106677 |
0.9587 | High Similarity | NPC83218 |
0.9587 | High Similarity | NPC126991 |
0.958 | High Similarity | NPC11724 |
0.9508 | High Similarity | NPC471157 |
0.9496 | High Similarity | NPC476872 |
0.9435 | High Similarity | NPC253595 |
0.9431 | High Similarity | NPC288416 |
0.9355 | High Similarity | NPC225307 |
0.9286 | High Similarity | NPC478255 |
0.9274 | High Similarity | NPC156692 |
0.9274 | High Similarity | NPC471882 |
0.9274 | High Similarity | NPC173150 |
0.9274 | High Similarity | NPC35288 |
0.9274 | High Similarity | NPC45224 |
0.9274 | High Similarity | NPC471881 |
0.9134 | High Similarity | NPC138777 |
0.9134 | High Similarity | NPC235294 |
0.9134 | High Similarity | NPC46137 |
0.9134 | High Similarity | NPC225384 |
0.9134 | High Similarity | NPC246869 |
0.9134 | High Similarity | NPC254819 |
0.9127 | High Similarity | NPC477294 |
0.9127 | High Similarity | NPC477293 |
0.9127 | High Similarity | NPC229784 |
0.9062 | High Similarity | NPC473924 |
0.9062 | High Similarity | NPC473285 |
0.9048 | High Similarity | NPC232880 |
0.904 | High Similarity | NPC61181 |
0.8992 | High Similarity | NPC28637 |
0.8992 | High Similarity | NPC254398 |
0.8984 | High Similarity | NPC281798 |
0.8984 | High Similarity | NPC219677 |
0.8968 | High Similarity | NPC476873 |
0.8968 | High Similarity | NPC103533 |
0.8931 | High Similarity | NPC472132 |
0.8923 | High Similarity | NPC287597 |
0.8923 | High Similarity | NPC34293 |
0.8923 | High Similarity | NPC886 |
0.8908 | High Similarity | NPC313193 |
0.8855 | High Similarity | NPC476870 |
0.8855 | High Similarity | NPC263829 |
0.8828 | High Similarity | NPC295970 |
0.8824 | High Similarity | NPC474641 |
0.8797 | High Similarity | NPC321184 |
0.8797 | High Similarity | NPC171134 |
0.8797 | High Similarity | NPC49597 |
0.8797 | High Similarity | NPC321638 |
0.8797 | High Similarity | NPC328273 |
0.8788 | High Similarity | NPC166180 |
0.8788 | High Similarity | NPC471345 |
0.8779 | High Similarity | NPC169398 |
0.8779 | High Similarity | NPC471883 |
0.876 | High Similarity | NPC175771 |
0.8722 | High Similarity | NPC78363 |
0.8722 | High Similarity | NPC476376 |
0.8722 | High Similarity | NPC260425 |
0.8672 | High Similarity | NPC140750 |
0.8667 | High Similarity | NPC46644 |
0.8657 | High Similarity | NPC205195 |
0.8657 | High Similarity | NPC31745 |
0.8657 | High Similarity | NPC81515 |
0.8657 | High Similarity | NPC220936 |
0.8657 | High Similarity | NPC472350 |
0.8657 | High Similarity | NPC476383 |
0.8657 | High Similarity | NPC64141 |
0.8657 | High Similarity | NPC68092 |
0.8657 | High Similarity | NPC197316 |
0.8657 | High Similarity | NPC89105 |
0.8647 | High Similarity | NPC470572 |
0.8647 | High Similarity | NPC157554 |
0.8615 | High Similarity | NPC470079 |
0.8607 | High Similarity | NPC148055 |
0.8605 | High Similarity | NPC146540 |
0.8603 | High Similarity | NPC469623 |
0.8603 | High Similarity | NPC148080 |
0.8595 | High Similarity | NPC157338 |
0.8593 | High Similarity | NPC202700 |
0.8582 | High Similarity | NPC469364 |
0.8582 | High Similarity | NPC65262 |
0.8582 | High Similarity | NPC101686 |
0.8561 | High Similarity | NPC114116 |
0.856 | High Similarity | NPC201402 |
0.856 | High Similarity | NPC476448 |
0.856 | High Similarity | NPC160854 |
0.856 | High Similarity | NPC469703 |
0.856 | High Similarity | NPC476445 |
0.856 | High Similarity | NPC469704 |
0.856 | High Similarity | NPC469548 |
0.854 | High Similarity | NPC105005 |
0.854 | High Similarity | NPC204644 |
0.854 | High Similarity | NPC478250 |
0.854 | High Similarity | NPC40305 |
0.8538 | High Similarity | NPC469549 |
0.8529 | High Similarity | NPC47471 |
0.8529 | High Similarity | NPC186406 |
0.8529 | High Similarity | NPC134405 |
0.8529 | High Similarity | NPC476385 |
0.8529 | High Similarity | NPC476377 |
0.8519 | High Similarity | NPC220942 |
0.8519 | High Similarity | NPC226005 |
0.8519 | High Similarity | NPC100389 |
0.8507 | High Similarity | NPC37468 |
0.8507 | High Similarity | NPC186418 |
0.8504 | High Similarity | NPC232454 |
0.8504 | High Similarity | NPC178449 |
0.8504 | High Similarity | NPC470907 |
0.8492 | Intermediate Similarity | NPC55608 |
0.8492 | Intermediate Similarity | NPC469686 |
0.848 | Intermediate Similarity | NPC282409 |
0.848 | Intermediate Similarity | NPC469702 |
0.8478 | Intermediate Similarity | NPC63304 |
0.8478 | Intermediate Similarity | NPC251062 |
0.8478 | Intermediate Similarity | NPC110063 |
0.8478 | Intermediate Similarity | NPC296954 |
0.8478 | Intermediate Similarity | NPC300894 |
0.8478 | Intermediate Similarity | NPC141455 |
0.8478 | Intermediate Similarity | NPC196063 |
0.8478 | Intermediate Similarity | NPC184464 |
0.8467 | Intermediate Similarity | NPC145319 |
0.8467 | Intermediate Similarity | NPC157816 |
0.8467 | Intermediate Similarity | NPC265648 |
0.8467 | Intermediate Similarity | NPC140502 |
0.8467 | Intermediate Similarity | NPC222433 |
0.8456 | Intermediate Similarity | NPC473799 |
0.8456 | Intermediate Similarity | NPC475530 |
0.8433 | Intermediate Similarity | NPC320259 |
0.8433 | Intermediate Similarity | NPC185778 |
0.8425 | Intermediate Similarity | NPC471067 |
0.8417 | Intermediate Similarity | NPC475528 |
0.8413 | Intermediate Similarity | NPC229600 |
0.8406 | Intermediate Similarity | NPC264632 |
0.8406 | Intermediate Similarity | NPC88754 |
0.8406 | Intermediate Similarity | NPC76406 |
0.8406 | Intermediate Similarity | NPC476380 |
0.8406 | Intermediate Similarity | NPC476375 |
0.8406 | Intermediate Similarity | NPC298257 |
0.8406 | Intermediate Similarity | NPC293154 |
0.8406 | Intermediate Similarity | NPC96795 |
0.8406 | Intermediate Similarity | NPC476378 |
0.8406 | Intermediate Similarity | NPC205864 |
0.8406 | Intermediate Similarity | NPC112 |
0.8406 | Intermediate Similarity | NPC478239 |
0.8406 | Intermediate Similarity | NPC476397 |
0.8406 | Intermediate Similarity | NPC175214 |
0.8406 | Intermediate Similarity | NPC116104 |
0.8406 | Intermediate Similarity | NPC237872 |
0.8406 | Intermediate Similarity | NPC263397 |
0.8406 | Intermediate Similarity | NPC247032 |
0.8406 | Intermediate Similarity | NPC302286 |
0.8406 | Intermediate Similarity | NPC476384 |
0.8406 | Intermediate Similarity | NPC119537 |
0.8406 | Intermediate Similarity | NPC476381 |
0.8406 | Intermediate Similarity | NPC269141 |
0.8403 | Intermediate Similarity | NPC184633 |
0.8394 | Intermediate Similarity | NPC7518 |
0.8394 | Intermediate Similarity | NPC154262 |
0.8394 | Intermediate Similarity | NPC476442 |
0.8394 | Intermediate Similarity | NPC215512 |
0.8394 | Intermediate Similarity | NPC159387 |
0.8394 | Intermediate Similarity | NPC137501 |
0.837 | Intermediate Similarity | NPC103409 |
0.8357 | Intermediate Similarity | NPC119773 |
0.8357 | Intermediate Similarity | NPC229505 |
0.8357 | Intermediate Similarity | NPC475539 |
0.8357 | Intermediate Similarity | NPC291153 |
0.8357 | Intermediate Similarity | NPC143246 |
0.8357 | Intermediate Similarity | NPC474268 |
0.8347 | Intermediate Similarity | NPC470825 |
0.8345 | Intermediate Similarity | NPC476867 |
0.8345 | Intermediate Similarity | NPC296659 |
0.8345 | Intermediate Similarity | NPC202391 |
0.8345 | Intermediate Similarity | NPC232228 |
0.8345 | Intermediate Similarity | NPC292443 |
0.8345 | Intermediate Similarity | NPC77922 |
0.8345 | Intermediate Similarity | NPC64195 |
0.8345 | Intermediate Similarity | NPC473281 |
0.8333 | Intermediate Similarity | NPC469705 |
0.8333 | Intermediate Similarity | NPC17968 |
0.8333 | Intermediate Similarity | NPC470122 |
0.8333 | Intermediate Similarity | NPC296643 |
0.8321 | Intermediate Similarity | NPC158673 |
0.831 | Intermediate Similarity | NPC478242 |
0.8309 | Intermediate Similarity | NPC124149 |
0.8298 | Intermediate Similarity | NPC18789 |
0.8295 | Intermediate Similarity | NPC287429 |
0.8286 | Intermediate Similarity | NPC262182 |
0.8286 | Intermediate Similarity | NPC34587 |
0.8286 | Intermediate Similarity | NPC476869 |
0.8286 | Intermediate Similarity | NPC476866 |
0.8286 | Intermediate Similarity | NPC252292 |
0.8286 | Intermediate Similarity | NPC476868 |
0.8286 | Intermediate Similarity | NPC100998 |
0.8286 | Intermediate Similarity | NPC83743 |
0.8286 | Intermediate Similarity | NPC34927 |
0.8286 | Intermediate Similarity | NPC216819 |
0.8286 | Intermediate Similarity | NPC476864 |
0.8286 | Intermediate Similarity | NPC287615 |
0.8286 | Intermediate Similarity | NPC476382 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC252114 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8657 | High Similarity | NPD7266 | Discontinued |
0.7931 | Intermediate Similarity | NPD1653 | Approved |
0.7923 | Intermediate Similarity | NPD1091 | Approved |
0.7762 | Intermediate Similarity | NPD6190 | Approved |
0.7516 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.748 | Intermediate Similarity | NPD969 | Suspended |
0.744 | Intermediate Similarity | NPD1358 | Approved |
0.7394 | Intermediate Similarity | NPD4978 | Clinical (unspecified phase) |
0.7348 | Intermediate Similarity | NPD9545 | Approved |
0.726 | Intermediate Similarity | NPD1652 | Phase 2 |
0.7222 | Intermediate Similarity | NPD3134 | Approved |
0.7208 | Intermediate Similarity | NPD8455 | Phase 2 |
0.7178 | Intermediate Similarity | NPD7685 | Pre-registration |
0.7153 | Intermediate Similarity | NPD7097 | Phase 1 |
0.7133 | Intermediate Similarity | NPD5123 | Clinical (unspecified phase) |
0.7133 | Intermediate Similarity | NPD5124 | Phase 1 |
0.7133 | Intermediate Similarity | NPD4340 | Discontinued |
0.7124 | Intermediate Similarity | NPD4380 | Phase 2 |
0.7095 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7073 | Intermediate Similarity | NPD6559 | Discontinued |
0.7042 | Intermediate Similarity | NPD3764 | Approved |
0.7037 | Intermediate Similarity | NPD3818 | Discontinued |
0.703 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.7029 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.7014 | Intermediate Similarity | NPD230 | Phase 1 |
0.7007 | Intermediate Similarity | NPD422 | Phase 1 |
0.7 | Intermediate Similarity | NPD5058 | Phase 3 |
0.6994 | Remote Similarity | NPD7054 | Approved |
0.6994 | Remote Similarity | NPD7804 | Clinical (unspecified phase) |
0.6993 | Remote Similarity | NPD6233 | Phase 2 |
0.6985 | Remote Similarity | NPD5126 | Approved |
0.6985 | Remote Similarity | NPD5125 | Phase 3 |
0.6972 | Remote Similarity | NPD3027 | Phase 3 |
0.6962 | Remote Similarity | NPD7075 | Discontinued |
0.6954 | Remote Similarity | NPD6143 | Clinical (unspecified phase) |
0.6951 | Remote Similarity | NPD7472 | Approved |
0.6951 | Remote Similarity | NPD7074 | Phase 3 |
0.6944 | Remote Similarity | NPD1612 | Clinical (unspecified phase) |
0.6944 | Remote Similarity | NPD1613 | Approved |
0.6928 | Remote Similarity | NPD5403 | Approved |
0.6912 | Remote Similarity | NPD1357 | Approved |
0.6909 | Remote Similarity | NPD6797 | Phase 2 |
0.6899 | Remote Similarity | NPD4868 | Clinical (unspecified phase) |
0.6894 | Remote Similarity | NPD7843 | Approved |
0.6886 | Remote Similarity | NPD8312 | Approved |
0.6886 | Remote Similarity | NPD8313 | Approved |
0.6867 | Remote Similarity | NPD8166 | Discontinued |
0.6867 | Remote Similarity | NPD7251 | Discontinued |
0.6867 | Remote Similarity | NPD1878 | Clinical (unspecified phase) |
0.6846 | Remote Similarity | NPD2424 | Discontinued |
0.6846 | Remote Similarity | NPD2684 | Approved |
0.6829 | Remote Similarity | NPD7228 | Approved |
0.6828 | Remote Similarity | NPD7966 | Clinical (unspecified phase) |
0.6826 | Remote Similarity | NPD7808 | Phase 3 |
0.6815 | Remote Similarity | NPD37 | Approved |
0.6815 | Remote Similarity | NPD6801 | Discontinued |
0.6813 | Remote Similarity | NPD6234 | Discontinued |
0.6806 | Remote Similarity | NPD6798 | Discontinued |
0.6805 | Remote Similarity | NPD8055 | Clinical (unspecified phase) |
0.6802 | Remote Similarity | NPD7879 | Clinical (unspecified phase) |
0.68 | Remote Similarity | NPD7421 | Clinical (unspecified phase) |
0.6797 | Remote Similarity | NPD5401 | Approved |
0.6792 | Remote Similarity | NPD4967 | Phase 2 |
0.6792 | Remote Similarity | NPD4966 | Approved |
0.6792 | Remote Similarity | NPD4965 | Approved |
0.6772 | Remote Similarity | NPD7096 | Clinical (unspecified phase) |
0.6769 | Remote Similarity | NPD290 | Approved |
0.6769 | Remote Similarity | NPD9265 | Clinical (unspecified phase) |
0.6763 | Remote Similarity | NPD3705 | Approved |
0.6757 | Remote Similarity | NPD7033 | Discontinued |
0.6755 | Remote Similarity | NPD3750 | Approved |
0.6741 | Remote Similarity | NPD7157 | Approved |
0.6738 | Remote Similarity | NPD3225 | Approved |
0.6733 | Remote Similarity | NPD1549 | Phase 2 |
0.6732 | Remote Similarity | NPD6799 | Approved |
0.673 | Remote Similarity | NPD5402 | Approved |
0.6727 | Remote Similarity | NPD3751 | Discontinued |
0.6715 | Remote Similarity | NPD1548 | Phase 1 |
0.6713 | Remote Similarity | NPD2861 | Phase 2 |
0.6712 | Remote Similarity | NPD4060 | Phase 1 |
0.671 | Remote Similarity | NPD6980 | Clinical (unspecified phase) |
0.6694 | Remote Similarity | NPD2934 | Approved |
0.6694 | Remote Similarity | NPD2933 | Approved |
0.6694 | Remote Similarity | NPD689 | Discontinued |
0.6691 | Remote Similarity | NPD9493 | Approved |
0.6691 | Remote Similarity | NPD694 | Clinical (unspecified phase) |
0.6691 | Remote Similarity | NPD3496 | Discontinued |
0.669 | Remote Similarity | NPD6859 | Clinical (unspecified phase) |
0.6689 | Remote Similarity | NPD4536 | Approved |
0.6689 | Remote Similarity | NPD6674 | Discontinued |
0.6689 | Remote Similarity | NPD4537 | Clinical (unspecified phase) |
0.6689 | Remote Similarity | NPD4538 | Approved |
0.6688 | Remote Similarity | NPD8389 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD4908 | Phase 1 |
0.6667 | Remote Similarity | NPD1550 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD1552 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD1529 | Clinical (unspecified phase) |
0.6646 | Remote Similarity | NPD7411 | Suspended |
0.6645 | Remote Similarity | NPD6398 | Clinical (unspecified phase) |
0.6644 | Remote Similarity | NPD5960 | Phase 3 |
0.6644 | Remote Similarity | NPD4062 | Phase 3 |
0.6644 | Remote Similarity | NPD5588 | Approved |
0.6643 | Remote Similarity | NPD1610 | Phase 2 |
0.6643 | Remote Similarity | NPD5647 | Approved |
0.6642 | Remote Similarity | NPD5536 | Phase 2 |
0.6642 | Remote Similarity | NPD5535 | Approved |
0.664 | Remote Similarity | NPD2860 | Approved |
0.664 | Remote Similarity | NPD2859 | Approved |
0.6624 | Remote Similarity | NPD7458 | Discontinued |
0.6622 | Remote Similarity | NPD6653 | Approved |
0.6621 | Remote Similarity | NPD7095 | Approved |
0.662 | Remote Similarity | NPD8651 | Approved |
0.6618 | Remote Similarity | NPD4198 | Discontinued |
0.6607 | Remote Similarity | NPD7993 | Clinical (unspecified phase) |
0.6604 | Remote Similarity | NPD1934 | Approved |
0.6597 | Remote Similarity | NPD1530 | Clinical (unspecified phase) |
0.6593 | Remote Similarity | NPD1241 | Discontinued |
0.6581 | Remote Similarity | NPD3536 | Discontinued |
0.6575 | Remote Similarity | NPD4907 | Clinical (unspecified phase) |
0.6573 | Remote Similarity | NPD3094 | Phase 2 |
0.6565 | Remote Similarity | NPD968 | Approved |
0.6562 | Remote Similarity | NPD1242 | Phase 1 |
0.6562 | Remote Similarity | NPD2393 | Clinical (unspecified phase) |
0.6554 | Remote Similarity | NPD6355 | Discontinued |
0.6554 | Remote Similarity | NPD1933 | Approved |
0.6538 | Remote Similarity | NPD7314 | Clinical (unspecified phase) |
0.6533 | Remote Similarity | NPD1510 | Phase 2 |
0.6528 | Remote Similarity | NPD6007 | Clinical (unspecified phase) |
0.6525 | Remote Similarity | NPD1535 | Discovery |
0.6524 | Remote Similarity | NPD7199 | Phase 2 |
0.6522 | Remote Similarity | NPD3817 | Phase 2 |
0.6512 | Remote Similarity | NPD940 | Approved |
0.6512 | Remote Similarity | NPD846 | Approved |
0.6506 | Remote Similarity | NPD6166 | Phase 2 |
0.6506 | Remote Similarity | NPD6167 | Clinical (unspecified phase) |
0.6506 | Remote Similarity | NPD6168 | Clinical (unspecified phase) |
0.65 | Remote Similarity | NPD5238 | Clinical (unspecified phase) |
0.65 | Remote Similarity | NPD4626 | Approved |
0.65 | Remote Similarity | NPD6516 | Phase 2 |
0.65 | Remote Similarity | NPD5846 | Approved |
0.65 | Remote Similarity | NPD111 | Approved |
0.6494 | Remote Similarity | NPD8397 | Clinical (unspecified phase) |
0.649 | Remote Similarity | NPD1551 | Phase 2 |
0.649 | Remote Similarity | NPD2935 | Discontinued |
0.6489 | Remote Similarity | NPD9697 | Approved |
0.6485 | Remote Similarity | NPD3787 | Discontinued |
0.6484 | Remote Similarity | NPD3020 | Approved |
0.6483 | Remote Similarity | NPD5736 | Approved |
0.6479 | Remote Similarity | NPD1481 | Phase 2 |
0.6479 | Remote Similarity | NPD9269 | Phase 2 |
0.6478 | Remote Similarity | NPD6599 | Discontinued |
0.6475 | Remote Similarity | NPD1894 | Discontinued |
0.6474 | Remote Similarity | NPD8150 | Discontinued |
0.6471 | Remote Similarity | NPD7240 | Approved |
0.6471 | Remote Similarity | NPD5698 | Clinical (unspecified phase) |
0.6463 | Remote Similarity | NPD6410 | Clinical (unspecified phase) |
0.6463 | Remote Similarity | NPD3268 | Approved |
0.6462 | Remote Similarity | NPD6647 | Phase 2 |
0.646 | Remote Similarity | NPD7819 | Suspended |
0.6458 | Remote Similarity | NPD1203 | Approved |
0.6458 | Remote Similarity | NPD2797 | Approved |
0.6458 | Remote Similarity | NPD1049 | Clinical (unspecified phase) |
0.6454 | Remote Similarity | NPD3847 | Discontinued |
0.6447 | Remote Similarity | NPD2029 | Clinical (unspecified phase) |
0.6447 | Remote Similarity | NPD5763 | Approved |
0.6447 | Remote Similarity | NPD5762 | Approved |
0.6444 | Remote Similarity | NPD228 | Approved |
0.6441 | Remote Similarity | NPD6534 | Approved |
0.6441 | Remote Similarity | NPD6535 | Approved |
0.6434 | Remote Similarity | NPD4749 | Approved |
0.6434 | Remote Similarity | NPD3685 | Discontinued |
0.6429 | Remote Similarity | NPD7435 | Discontinued |
0.6429 | Remote Similarity | NPD5691 | Approved |
0.6424 | Remote Similarity | NPD3748 | Approved |
0.6423 | Remote Similarity | NPD690 | Clinical (unspecified phase) |
0.6418 | Remote Similarity | NPD3022 | Approved |
0.6418 | Remote Similarity | NPD3021 | Approved |
0.6418 | Remote Similarity | NPD9380 | Clinical (unspecified phase) |
0.6415 | Remote Similarity | NPD3455 | Phase 2 |
0.6408 | Remote Similarity | NPD3092 | Approved |
0.6395 | Remote Similarity | NPD5952 | Clinical (unspecified phase) |
0.6395 | Remote Similarity | NPD3180 | Approved |
0.6395 | Remote Similarity | NPD3179 | Approved |
0.6393 | Remote Similarity | NPD1282 | Approved |
0.6393 | Remote Similarity | NPD8320 | Phase 1 |
0.6393 | Remote Similarity | NPD8319 | Approved |
0.6391 | Remote Similarity | NPD8470 | Clinical (unspecified phase) |
0.6391 | Remote Similarity | NPD5844 | Phase 1 |
0.6383 | Remote Similarity | NPD1778 | Approved |
0.6377 | Remote Similarity | NPD6671 | Approved |
0.6376 | Remote Similarity | NPD4140 | Approved |
0.6376 | Remote Similarity | NPD1240 | Approved |
0.637 | Remote Similarity | NPD9494 | Approved |
0.6369 | Remote Similarity | NPD4378 | Clinical (unspecified phase) |
0.6369 | Remote Similarity | NPD7004 | Clinical (unspecified phase) |
0.6369 | Remote Similarity | NPD7410 | Clinical (unspecified phase) |
0.6364 | Remote Similarity | NPD5048 | Discontinued |
0.6364 | Remote Similarity | NPD9717 | Approved |
0.6358 | Remote Similarity | NPD2801 | Approved |
0.6354 | Remote Similarity | NPD6776 | Approved |
PubChem CID   | 10367075 |
ChEMBL   | CHEMBL477535 |
ZINC   |
Molecular Weight:   | 462.15 |
ALogP:   | -2.5004 |
MLogP:   | 2.89 |
XLogP:   | 0.551 |
# Rotatable Bonds:   | 14 |
Polar Surface Area:   | 162.98 |
# H-Bond Aceptor:   | 9 |
# H-Bond Donor:   | 5 |
# Rings:   | 3 |
# Heavy Atoms:   | 33 |